Enorama Pharma AB (ERMA) — Financial Flexibility Index
Enorama Pharma AB (ERMA) has a Financial Flexibility Index of -0.20x as of March 2026. Free cash flow of Skr-12.09 Million (operating CF Skr-12.09 Million minus capex Skr0.00) represents 0% of total liabilities (Skr59.58 Million). Check ERMA capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Enorama Pharma AB Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Enorama Pharma AB across 12 annual periods. See ERMA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Enorama Pharma AB (2014–2025)
Year-by-year free cash flow to debt coverage for Enorama Pharma AB. For the full company profile including market capitalisation, see Enorama Pharma AB market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Skr0.00 | Skr-59.26 Million | Skr31.71 Million | ▲ +100.0% |
| 2024 | -4.41x | Skr-35.70 Million | Skr-35.70 Million | Skr8.09 Million | ▼ -58.4% |
| 2023 | -2.79x | Skr-41.35 Million | Skr-41.35 Million | Skr14.85 Million | ▼ -45.3% |
| 2022 | -1.92x | Skr-32.96 Million | Skr-32.96 Million | Skr17.20 Million | ▼ -100.0% |
| 2021 | -0.96x | Skr-28.34 Million | Skr-30.16 Million | Skr29.58 Million | ▼ -95.6% |
| 2020 | -0.49x | Skr-19.16 Million | Skr-23.00 Million | Skr39.13 Million | ▲ +22.6% |
| 2019 | -0.63x | Skr-22.39 Million | Skr-26.56 Million | Skr35.40 Million | ▼ -122.9% |
| 2018 | -0.28x | Skr-6.19 Million | Skr-13.36 Million | Skr21.81 Million | ▲ +21.4% |
| 2017 | -0.36x | Skr-2.93 Million | Skr-6.67 Million | Skr8.13 Million | ▲ +22.7% |
| 2016 | -0.47x | Skr-2.12 Million | Skr-6.11 Million | Skr4.55 Million | ▼ -149.9% |
| 2015 | 0.94x | Skr2.47 Million | Skr480.00K | Skr2.64 Million | ▼ -42.8% |
| 2014 | 1.63x | Skr1.69 Million | Skr307.00K | Skr1.03 Million | — |